- Home
- /
- News
- /
- Drug Trials
- /
- October 2009
Drug Trials News for October 2009
Human Genome Sciences, Inc. and GlaxoSmithKline PLC recently announced the full presentation of results from BLISS-52, the first of two Phase III trials of BENLYSTA™ (belimumab) in seropositive patients with systemic lupus erythematosus.
27 October, 2009
New results have shown that the novel biological therapy ACZ885 (canakinumab) is significantly more effective than an injectable corticosteroid at reducing pain and preventing recurrent attacks or ‘flares’ in patients with hard-to-treat gout, one of the most painful forms of arthritis.
26 October, 2009
GlaxoSmithKline (GSK) has recently announced the final results from its four-year combination therapy with Avodart and tamsulosin (CombAT) study.
16 October, 2009
Data presented at the American Society of Retina Specialists Conference in New York.
12 October, 2009
Olesoxime in ongoing pivotal efficacy study for amyotrophic lateral sclerosis.
08 October, 2009